Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00033228
Status:
COMPLETED
Last Update Posted:
2011-05-12
First Post:
2002-04-09
Brief Title:
Vaccine Therapy in Treating Patients With Stage IV Melanoma
Sponsor:
Mannkind Corporation
Organization:
Mannkind Corporation
Organization Data
Organization:
Mannkind Corporation
Class:
INDUSTRY
Study ID:
CDR0000069252
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mannkind Corporation
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Chief Scientific Officer
Old Organization:
Mannkind Coorporation